PacBio (NASDAQ:PACB) Reports Sales Below Analyst Estimates In Q3 Earnings [Yahoo! Finance]
Pacific Biosciences of California, Inc. (PACB)
Last pacific biosciences of california, inc. earnings: 2/6 04:02 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investor.pacificbiosciences.com
Company Research
Source: Yahoo! Finance
Its non-GAAP loss of $0.12 per share was 14.2% above analysts' consensus estimates. Is now the time to buy PacBio? Find out in our full research report PacBio (PACB) Q3 CY2025 Highlights: Revenue: $38.44 million vs analyst estimates of $40.24 million (3.8% year-on-year decline, 4.5% miss) Adjusted EPS: -$0.12 vs analyst estimates of -$0.14 (14.2% beat) Adjusted EBITDA: -$38.04 million vs analyst estimates of -$38.36 million (-99% margin, 0.8% beat) Operating Margin: -101%, up from -160% in the same quarter last year Market Capitalization: $600.7 million “While revenue came in slightly below our expectations this quarter, we achieved another all-time record for consumable revenue, expanded gross margins and continued to reduce our operating expenses,” said Christian Henry, President and Chief Executive Officer. Company Overview Pioneering what scientists call "HiFi long-read sequencing," recognized as Nature Methods' method of the year for 2022, Pacific Biosciences
Show less
Read more
Impact Snapshot
Event Time:
PACB
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PACB alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PACB alerts
High impacting Pacific Biosciences of California, Inc. news events
Weekly update
A roundup of the hottest topics
PACB
News
- Why PacBio (PACB) Stock Is Up Today [Yahoo! Finance]Yahoo! Finance
- PacBio to Participate in the Piper Sandler 37th Annual Healthcare Conference [Yahoo! Finance]Yahoo! Finance
- PacBio to Participate in the Piper Sandler 37th Annual Healthcare ConferenceGlobeNewswire
- How Recent Moves Are Rewriting the Story for PacBio Amid Shifting Analyst Sentiment [Yahoo! Finance]Yahoo! Finance
- Broken String Biosciences Announces New Leadership to Drive Commercialization of INDUCE-seq® Platform for Gene Editing On- and Off-target Characterization [Yahoo! Finance]Yahoo! Finance
PACB
Earnings
- 11/5/25 - Beat
PACB
Analyst Actions
- 11/10/25 - Stephens & Co.
PACB
Sec Filings
- 11/14/25 - Form SCHEDULE
- 11/6/25 - Form 10-Q
- 11/5/25 - Form 8-K
- PACB's page on the SEC website